Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to DiseaseAlessandra Feraco, Massimiliano Caprio, Vincenzo Marzolla et al.|Trends in Endocrinology and Metabolism|2019Cited by 76
The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathwayVincenzo Marzolla, Massimiliano Caprio, Alessandra Feraco et al.|The FASEB Journal|2020Cited by 69
Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndromeVincenzo Marzolla, Massimiliano Caprio, Massimo U. De Martino et al.|Steroids|2014Cited by 65
Neuroendocrine and Metabolic Effects of Low-Calorie and Non-Calorie SweetenersEleonora Moriconi, Massimiliano Caprio, Alessandra Feraco et al.|Frontiers in Endocrinology|2020Cited by 64
SIRT5 Inhibition Induces Brown Fat-Like Phenotype in 3T3-L1 PreadipocytesFrancesca Molinari, Andrea Armani, Alessandra Feraco et al.|Cells|2021Cited by 34